Lexaria Bioscience Corp’s ( NASDAQ: LEXX/ CSE: LXX;) proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier delivery methods and increasing the effectiveness of fat-soluble active molecules and drugs.
The Company’s technology can be applied to many different drugs and other active ingredients such as vitamins in oral formats including tablets, capsules, oral suspensions – and even foods, beverages, and topical preparations.
DehydraTECH:
increases bio-absorption by up to 5x, reduces time of onset from up to 1 – 2 hours to just minutes masks unwanted tastes. and can reduce unwanted side effects by enabling lower overall dosing.
DehydraTECH is one of the world’s newest technologies specifically designed to improve the efficacy of orally administered bioactive molecules, including anti-viral drugs, nicotine, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), and other molecules. …...more
...more
Show less
